Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 4
2019 8
2020 6
2021 5
2022 3
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean naoko tomonobu (1 results)?
Lysyl oxidase-like 4 promotes the invasiveness of triple-negative breast cancer cells by orchestrating the invasive machinery formed by annexin A2 and S100A11 on the cell surface.
Takahashi T, Tomonobu N, Kinoshita R, Yamamoto KI, Murata H, Komalasari NLGY, Chen Y, Jiang F, Gohara Y, Ochi T, Ruma IMW, Sumardika IW, Zhou J, Honjo T, Sakaguchi Y, Yamauchi A, Kuribayashi F, Kondo E, Inoue Y, Futami J, Toyooka S, Zamami Y, Sakaguchi M. Takahashi T, et al. Among authors: tomonobu n. Front Oncol. 2024 Mar 26;14:1371342. doi: 10.3389/fonc.2024.1371342. eCollection 2024. Front Oncol. 2024. PMID: 38595825 Free PMC article.
Lysyl oxidase-like 4 exerts an atypical role in breast cancer progression that is dependent on the enzymatic activity that targets the cell-surface annexin A2.
Komalasari NLGY, Tomonobu N, Kinoshita R, Chen Y, Sakaguchi Y, Gohara Y, Jiang F, Yamamoto KI, Murata H, Ruma IMW, Sumardika IW, Zhou J, Yamauchi A, Kuribayashi F, Inoue Y, Toyooka S, Sakaguchi M. Komalasari NLGY, et al. Among authors: tomonobu n. Front Oncol. 2023 Apr 4;13:1142907. doi: 10.3389/fonc.2023.1142907. eCollection 2023. Front Oncol. 2023. PMID: 37091157 Free PMC article.
LOXL1 and LOXL4 are novel target genes of the Zn2+-bound form of ZEB1 and play a crucial role in the acceleration of invasive events in triple-negative breast cancer cells.
Hirabayashi D, Yamamoto KI, Maruyama A, Tomonobu N, Kinoshita R, Chen Y, Komalasari NLGY, Murata H, Gohara Y, Jiang F, Zhou J, Ruma IMW, Sumardika IW, Yamauchi A, Kuribayashi F, Toyooka S, Inoue Y, Sakaguchi M. Hirabayashi D, et al. Among authors: tomonobu n. Front Oncol. 2023 Feb 23;13:1142886. doi: 10.3389/fonc.2023.1142886. eCollection 2023. Front Oncol. 2023. PMID: 36910659 Free PMC article.
Novel extracellular role of REIC/Dkk-3 protein in PD-L1 regulation in cancer cells.
Gohara Y, Tomonobu N, Kinoshita R, Futami J, Audebert L, Chen Y, Komalasari NLGY, Jiang F, Yoshizawa C, Murata H, Yamamoto KI, Watanabe M, Kumon H, Sakaguchi M. Gohara Y, et al. Among authors: tomonobu n. J Mol Med (Berl). 2023 Apr;101(4):431-447. doi: 10.1007/s00109-023-02292-w. Epub 2023 Mar 4. J Mol Med (Berl). 2023. PMID: 36869893 Free PMC article.
PD-1 blockade augments CD8+ T cell dependent antitumor immunity triggered by Ad-SGE-REIC in Egfr-mutant lung cancer.
Nakasuka T, Ohashi K, Nishii K, Hirabae A, Okawa S, Tomonobu N, Takada K, Ando C, Watanabe H, Makimoto G, Ninomiya K, Fujii M, Kubo T, Ichihara E, Hotta K, Tabata M, Kumon H, Maeda Y, Kiura K. Nakasuka T, et al. Among authors: tomonobu n. Lung Cancer. 2023 Apr;178:1-10. doi: 10.1016/j.lungcan.2023.01.018. Epub 2023 Feb 1. Lung Cancer. 2023. PMID: 36753780
Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migration inhibitor by an in vitro chemotaxis assay.
Okamoto S, Miyano K, Choshi T, Sugisawa N, Nishiyama T, Kotouge R, Yamamura M, Sakaguchi M, Kinoshita R, Tomonobu N, Katase N, Sasaki K, Nishina S, Hino K, Kurose K, Oka M, Kubota H, Ueno T, Hirai T, Fujiwara H, Kawai C, Itadani M, Morihara A, Matsushima K, Kanegasaki S, Hoffman RM, Yamauchi A, Kuribayashi F. Okamoto S, et al. Among authors: tomonobu n. Biomed Pharmacother. 2022 Nov;155:113733. doi: 10.1016/j.biopha.2022.113733. Epub 2022 Sep 29. Biomed Pharmacother. 2022. PMID: 36271542 Free article.
Toll-like receptor 4 promotes bladder cancer progression upon S100A8/A9 binding, which requires TIRAP-mediated TPL2 activation.
Herik Rodrigo AG, Tomonobu N, Yoneda H, Kinoshita R, Mitsui Y, Sadahira T, Terawaki SI, Gohara Y, Gede Yoni Komalasari NL, Jiang F, Murata H, Yamamoto KI, Futami J, Yamauchi A, Kuribayashi F, Inoue Y, Kondo E, Toyooka S, Nishibori M, Watanabe M, Nasu Y, Sakaguchi M. Herik Rodrigo AG, et al. Among authors: tomonobu n. Biochem Biophys Res Commun. 2022 Dec 17;634:83-91. doi: 10.1016/j.bbrc.2022.09.116. Epub 2022 Oct 6. Biochem Biophys Res Commun. 2022. PMID: 36240653 Free article.
33 results